(Reuters) - Shares in the Nottingham-based firm, which helps researchers
conduct clinical trials, dropped 36.4 percent to 79.5 pence,
valuing the company at 52.8 million pounds .
Clinphone said service levels dropped during June and July
because of outages from third-party telecoms suppliers as well
as internal data processing problems.
Read more at Reuters.com Market News
conduct clinical trials, dropped 36.4 percent to 79.5 pence,
valuing the company at 52.8 million pounds .
Clinphone said service levels dropped during June and July
because of outages from third-party telecoms suppliers as well
as internal data processing problems.
Read more at Reuters.com Market News
No comments:
Post a Comment